CordenPharma Brochures
-
Generic API List
7/8/2020
For generic drug companies, we supply Active Pharmaceutical Ingredients (APIs), including controlled substances, for pain management, cardiovascular, gastrointestinal, central nervous system, anti-infective and respiratory indications. We manufacture these products using complex chemistry and technical expertise while maintaining a long-standing reputation of quality and reliability.
-
Readily Available Derivatized Phospholipids
7/8/2020
CordenPharma’s expert lipid manufacturers have mastered the chemical total synthesis of complex phospholipid derivatives from multi-gram to multi-kilogram scale and are renowned for their contract lipid and phospholipid molecule manufacturing expertise.
-
Injectables Technology Platform
6/15/2020
Corden Pharma offers you a broad spectrum of injectable services starting from early formulation development to full commercial scale, covering both terminal sterilization & aseptic filling technologies for prefilled syringes (PFS), vials, ampoules, cartridges and lyophilized vials, with a range of filling volumes including the capability for combination products.
-
Highly Potent & Oncology Technology Platform
6/15/2020
The Highly Potent & Oncology platform offers over 30 years of experience in the development and production of highly potent compounds. Our extensive capabilities enable us to support your project from clinical through commercialization.
-
Peptides, Lipids And Carbohydrates Technology Platform
6/15/2020
Our scientists have mastered the core principles of synthesizing advanced bioorganic APIs, and bring them to bear on every project, large or small. The peptides, lipids & carbohydrates platform supplies you with a specialized combined expertise across three cGMP facilities in earlystage to commercial supply of advanced bioorganic APIs, including synthetic peptides, lipids, carbohydrates & conjugates.
-
Small Molecules Technology Platform
6/15/2020
Our integrated network of facilities brings a combined 200+ years of manufacturing experience to bear on your project, with over 1,200,000 Liters of volumetric capacity ranging from 20 L to 28,000 L reactors of various materials of construction. With our commercial track record we develop and advance your small molecule projects through clinical trials to commercial launch.
-
CordenPharma Overview
6/15/2020
CordenPharma is your full-service CMO partner in the contract development & manufacturing of pharmaceutical drug products, their active pharmaceutical ingredients (APIs), and associated packaging services.
-
Ionizable Lipids & Lipid Nanoparticles: Initiatives Like C12-200 Allow Lower Dose
6/29/2020
Significant effort has been applied to discover and develop vehicles which can guide small interfering siRNA through the many barriers guarding the interior of target cells. Improvements in delivery efficacy were required to fulfill the broadest potential of RNA interference therapeutics. Through the combinatorial synthesis and screening of a different class of materials, a formulation has been identified that enables siRNA-directed liver gene silencing in mice at doses below 0.01 mg∕kg.
-
CordenPharma Packaging Services
6/29/2020
CordenPharma Plankstadt is an internationally approved expert in contract manufacturing and packaging of solid dosage forms and part of CordenPharma’s network of facilities across Europe and the US. We provide multiple packaging solutions for oral solid forms ranging from standard packs for tablets and capsules to specialized packaging, e.g. multi-product blisters and packaging at low humidity.